Author(s):
Ayesha Siddiqua Gazi, Adeeba Mahveen, Sania Naaz, Saboor Arshi, Ramsha Fatima
Email(s):
adeebamahveen345@gmail.com
DOI:
10.52711/0975-4377.2026.00025 
Address:
Ayesha Siddiqua Gazi1, Adeeba Mahveen2*, Sania Naaz2, Saboor Arshi2, Ramsha Fatima2
1Assistant Professor, Dept of Pharmaceutics, Deccan School of Pharmacy, Hyderabad, Telangana, India.
2B. Pharmacy Student, Dept of Pharmaceutics, Deccan School of Pharmacy, Hyderabad, Telangana, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2026
ABSTRACT:
Nanotechnology is a rapidly advancing interdisciplinary domain that encompasses the design, synthesis, characterization, and application of materials and devices at the nanoscale, typically within the range of 1–100 nm. This field has significantly transformed numerous scientific and industrial sectors, including medicine, electronics, energy, and environmental sciences. In the pharmaceutical sciences, nanotechnology has become a cornerstone for developing innovative drug delivery systems such as nanosuspensions, liposomes, polymeric nanoparticles, metallic nanoparticles, and nanogels. These nano-based platforms enhance drug solubility, improve bioavailability, and enable precise and targeted delivery. The present review provides an in-depth understanding of the fundamental concepts of nanotechnology, various classes of nanoparticles, and their broad applications in pharmaceutics. It further outlines recent progress in nanotechnology-enabled drug delivery systems, with an emphasis on targeting mechanisms and their therapeutic applications in cancer, neurological disorders, and infectious diseases. Overall, nanotechnology continues to hold immense promise in redefining the future of pharmaceutical science by supporting the development of more effective, precise, and personalized therapeutic strategies.
Cite this article:
Ayesha Siddiqua Gazi, Adeeba Mahveen, Sania Naaz, Saboor Arshi, Ramsha Fatima. Nanotechnology: The Future of Targeted Drug Delivery and Controlled Drug Delivery in Pharmaceutics. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(2):163-1. doi: 10.52711/0975-4377.2026.00025
Cite(Electronic):
Ayesha Siddiqua Gazi, Adeeba Mahveen, Sania Naaz, Saboor Arshi, Ramsha Fatima. Nanotechnology: The Future of Targeted Drug Delivery and Controlled Drug Delivery in Pharmaceutics. Research Journal of Pharmaceutical Dosage Forms and Technology. 2026; 18(2):163-1. doi: 10.52711/0975-4377.2026.00025 Available on: https://www.rjpdft.com/AbstractView.aspx?PID=2026-18-2-11
REFERENCE:
1. G. A. Mansoori, Principles of Nanotechnology: Molecular-Based Study of Condensed Matter in Small Systems. Singapore: World Scientific, 2011.
2. C. Binns, Introduction to Nanoscience and Nanotechnology. Hoboken, NJ: Wiley, 2021.
3. M. C. Roco. The emergence and policy implications of converging new technologies. J. Nanopart. Res. 2005; 7(2–30: 129–143.
4. S. Mitragotri et al. Engineering of nanoparticles for targeted drug delivery. Nat. Rev. Drug Discov. 2022; 21(6): 424–448.
5. V. Torchilin. Multifunctional nanocarriers. Nat. Rev. Drug Discov. 2014; 13: 813–827.
6. R. Duncan and R. Gaspar. Nanomedicine—lessons learned. Adv. Drug Deliv. Rev. 2010; 62: 188–191.
7. M. E. Davis et al. Nanoparticle therapeutics: an emerging treatment modality. Nanomedicine. 2007; 2(6): 789–803.
8. S. Svenson. Dendrimers as versatile platform in drug delivery. Adv. Drug Deliv. Rev. 2005; 57: 2106–2129.
9. A. Akbarzadeh et al. Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 2013; 8: 102.
10. V. P. Torchilin. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release. 2001; 73: 137–172.
11. D. Peer et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007; 2: 751–760.
12. Y. H. Bae and K. Park. Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Release. 2011; 153: 198–205.
13. J. Shi et al. Nanotechnology in drug delivery and tissue engineering. J. Exp. Clin. Cancer Res. 2020; 39: 1–23.
14. H. Müller et al. Top-down and bottom-up engineered nanoparticles for drug delivery. Small. 2010; 6(20): 2336–2345.
15. R. H. Müller and K. Peters. Nanosuspensions for poorly soluble drugs. Adv. Drug Deliv. Rev. 2001; 47: 3–19.
16. M. R. J. Barocas et al. Supercritical fluid technology in pharmaceutical science. J. Supercrit. Fluids. 2018; 134: 40–52.
17. F. Alexis et al. Nanotechnology and future drug delivery. Curr. Opin. Pharmacol. 2008; 8: 339–345.
18. O. C. Farokhzad and R. Langer. Impact of nanotechnology on drug delivery. ACS Nano. 2009; 3: 16–20.
19. M. S. Islam and M. Rahman. Nanosuspension technology: recent progress in drug delivery. APS PharmSciTech. 2020; 21: 299–312.
20. X. Zhu et al. Nanotechnology in the diagnosis and treatment of coronary artery disease: recent progress and future perspectives. Adv. Drug Deliv. Rev. 2022; 182: 114097.
21. M. Li et al. Nanomaterial-based biosensors for cardiovascular biomarker detection. Biosens. Bioelectron. 2021; 171: 112687.
22. B. S. Wong et al. Nanoparticle-enhanced imaging for atherosclerosis. Nat. Rev. Cardiol. 2020; 17: 593–604.
23. J. Zhang et al. Biomimetic and natural nanoparticles for targeted cardiovascular therapy. ACS Nano. 2021; 15(2): 3119–3137.
24. J. J. Chong et al. Theranostic nanoplatforms for coronary artery disease. J. Control. Release. 2023; 355: 90–108.
25. R. Wilson and A. P. F. Turner. Glucose oxidase: an ideal enzyme. Biosens. Bioelectron. 1992; 7(3): 165–185.
26. R. Zhang and W. Xu. Nanotechnology in glucose monitoring: a review. Anal. Chim. Acta. 2014; 806: 1–12.
27. J. C. Pickup and F. Hussain. Nanomedicine and its potential in diabetes research and practice. Diabetes Metab. Res. Rev. 2015; 31(6): 604–610.
28. O. Veiseh, B. C. Tang, K. A. Whitehead, D. G. Anderson, and R. Langer. Managing diabetes with nanomedicine: challenges and opportunities. Nat. Rev. Drug Discov. 2015; 14: 45–57.
29. Z. Gu et al. Glucose-responsive micro/nanosystems for closed-loop insulin delivery. ACS Nano. 2013; 7(8): 6758–6766.
30. M. Montazer and T. Harifi, Nanotechnology in Textiles: Advances and Developments. Cambridge: Woodhead Publishing, 2018.
31. T. Shah, R. V. Adivarekar, and A. N. Desai. Application of nanotechnology in textiles. J. Text. Eng. Fashion Technol. 2015; 1(1): 1–7.
32. X. Wang and T. Lin. Nanotechnology for the textile industry: a review. J. Text. Inst. 2008; 99(2): 1–7.
33. H. M. C. De Azeredo. Nanocomposites for food packaging applications. Food Res. Int. 2009; 42(9): 1240–1253.
34. I. Holme. Innovative textile treatments using nanotechnology. Coloration Technol. 2007; 123(2): 59–73.
35. P. Jain, X. Huang, I. El-Sayed, and M. El-Sayed. Review of some interesting surface plasmon resonance-enhanced properties of noble metal nanoparticles. Chem. Phys. Lett. 2010; 487(4–6): 153–164.
36. M. De, P. S. Ghosh, and V. M. Rotello. Applications of nanoparticles in biology. Adv. Mater. 2008; 20(22): 4225–4241.
37. S. M. Moghimi, A. C. Hunter, and J. C. Murray. Nanomedicine: current status and future prospects. FASEB J. 2005; 19(3): 311–330.
38. K. S. Novoselov et al. A roadmap for grapheme. Nature. 2012; 490(7419): 192–200.
39. S. Iijima. Helical microtubules of graphitic carbon. Nature. 1991; 354: 56–58.
40. Foundational paper introducing carbon nanotubes — already covered by 39.
41. R. S. Varadan, L. Chen, and J. Xie, Nanomedicine: Design and Applications of Magnetic Nanomaterials, Nanosensors and Nanosystems. Hoboken, NJ: Wiley, 2008.
42. L. Zhang, F. Gu, and J. Chan. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 2008; 83(5): 761–769.
43. S. Bansal, M. Bansal, and R. Kumria. Nanocrystals: current strategies and trends. Int. J. Res. Pharm. Biomed. Sci. 2012; 3(1); 406–419.
44. D. Rasanta. Nanotechnology for the delivery of poorly water-soluble drugs. Global J. Pharm. Res. 2012; 1(3): 225–250.
45. M. Patel. Nanosuspension: a novel approach for drug delivery system. JPSBR. 2011; 1: 1–10.
46. G. V. Yadav.Nanosuspension: a promising drug delivery system. Pharmacophore. 2012; 3(5): 217–243.
47. A. Malik, S. Chaudhary, G. Garg, and A. Tomar. Dendrimers: a tool for drug delivery. Adv. Biol. Res. 2012; 6(4): 165–169.
48. P. Heera and S. Shanmugam. Nanoparticle characterization and application: an overview. Int. J. Curr. Microbiol. Appl. Sci. 2015; 4(8): 379–386.
49. S. M. Shahidulla, R. Miskan, and S. Sultana. Nanosuspensions in Pharmaceutical Sciences: A Comprehensive Review. International Journal of Health Sciences and Research. 2023; 13(7): 332-342 DOI: 10.52403/ijhsr.20230745.
50. Y. Mengesha. Nanotechnology-Enhanced Controlled-Release Systems in Topical Therapeutics. Precision Nanomedicine. 2024; 7(1): 1365-1385.
51. A. Di Stefano.Nanotechnology in Targeted Drug Delivery. International Journal of Molecular Sciences. 2023; 24(9): 8194 DOI: 10.3390/ijms24098194.
52. J. K. Patra et al. Recent developments and future prospects. Journal of Nanobiotechnology. 2018; 16(71). DOI: 10.1186/s12951-018-0392-8.
53. B. K. Yvon. The impact of nanoscience and nanotechnology on controlled drug delivery. Future Medicine: Nanomedicine. 2014; 9(4): 401 DOI: 10.2217/nnm.14.4.
54. H. B. Omietimi, S. A. Afolalu, J. F. Kayode, S. L. Monye, and S. Lawal. An overview of nanotechnology and its application. E3S Web of Conferences. 2023; 391: 01079. DOI: 10.1051/e3sconf/202339101079.
55. M. Rangasamy. Nano Technology: A Review. Journal of Applied Pharmaceutical Science. 2011; 1(20: 8-16.
56. S. R. H. Alhlimidi, S. H. K. Thillah A. Khadhum Al-musawi. Principles of Nanotechnology (Article review). International Journal of Multidisciplinary Research and Development. 2023; 10(7): 74-76.
57. C.-M. Gavrilescu, C. Paraschiv, P. Horjinec, D.-M. Sotrop, and R. M. Barbu. The advantages and disadvantages of nanotechnology. Romanian Journal of Oral Rehabilitation. 2018; 10(2): 153-157.
58. Rónavári et al. Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles. Powder Technology.
59. L. Marinelli et al. Preparation, Characterization, and Biological Evaluation of a Hydrophilic Peptide Loaded on PEG-PLGA Nanoparticles. Pharmaceutics. 2022; 14(9): 1821 DOI: 10.3390/pharmaceutics14091821.
60. B. K. R. Cacciatore et al. Multiple lipid nanoparticles as antimicrobial drug delivery systems. J. Drug Deliv. Sci. Technol. 2022; 67: 102887. DOI: 10.1016/j.jddst.2021.102887.